AU2002301208A1 - Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders - Google Patents

Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders

Info

Publication number
AU2002301208A1
AU2002301208A1 AU2002301208A AU2002301208A AU2002301208A1 AU 2002301208 A1 AU2002301208 A1 AU 2002301208A1 AU 2002301208 A AU2002301208 A AU 2002301208A AU 2002301208 A AU2002301208 A AU 2002301208A AU 2002301208 A1 AU2002301208 A1 AU 2002301208A1
Authority
AU
Australia
Prior art keywords
vasoproliferative
prophylaxis
disorders
therapy
factor vii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002301208A
Inventor
Christian Kannemeier
Sandip Kanse
Klaus T. Preissner
Juergen Roemisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
ZLB Behring GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZLB Behring GmbH filed Critical ZLB Behring GmbH
Publication of AU2002301208A1 publication Critical patent/AU2002301208A1/en
Assigned to ZLB BEHRING GMBH reassignment ZLB BEHRING GMBH Amend patent request/document other than specification (104) Assignors: AVENTIS BEHRING GMBH
Abandoned legal-status Critical Current

Links

AU2002301208A 2001-09-28 2002-09-26 Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders Abandoned AU2002301208A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10148037.7 2001-09-28

Publications (1)

Publication Number Publication Date
AU2002301208A1 true AU2002301208A1 (en) 2003-06-12

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
IL166363A0 (en) 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms pa in and incontinence
AU2002363411A1 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
AU2001233757A1 (en) Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2003259246A1 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2001249262A1 (en) Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
AU2002301208A1 (en) Use of coagulation factor VII - activating protease for the prophylaxis and therapy of vasoproliferative disorders
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
AU2002313379A1 (en) Antithrombin for the prevention and therapy of vasculoproliferative disorders
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2002313005B2 (en) Use of glycoprotein for the treatment and re-epithelisation of wounds
WO2002055064A3 (en) Mucopolysaccharidosis therapies
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders
AU2002330085A1 (en) Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders